Munich, Germany – April 8, 2003 – Bicoll GmbH, Munich announced today the four members of the
company’s Advisory Board. With Thorsten Bach, Ph.D., Hardy Debuch, Ph.D., K. Peter C. Vollhardt,
Ph.D., and Sina Afra, MBA, the Bicoll-Group will strengthen the company’s sustainable strategy for
modern drug design using its proprietary technology platform for natural product chemistry, combinatorial chemistry and screening techniques.